Search results
Why Is Verastem (VSTM) Stock Down 62% Today?
InvestorPlace· 21 hours agoVerastem (NASDAQ:VSTM) stock is falling hard on Friday following the release of new clinical trial data for its metastatic pancreatic cancer treatment.
Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data
Zacks via Yahoo Finance· 19 hours agoVerastem (VSTM) gains 57% post-market on achieving a confirmed partial response in 83% of first-line...
7 Things to Know About the Upcoming Nvidia (NVDA) Stock Split
InvestorPlace· 20 hours agoNvidia (NASDAQ:NVDA) stock is a hot topic on Friday after the company announced that it’s going to...
Ovarian cancer drug developer's stock cut in half after it files for FDA approval - Boston Business...
The Business Journals· 20 hours agoNeedham cancer drug developer Verastem Oncology saw its stock plunge over 60% Friday morning as of...
What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday?
Benzinga via Yahoo Finance· 21 hours agoThursday, Verastem Oncology (NASDAQ:VSTM) announced the initial interim safety and efficacy results...
Is the Stock Market Open on Memorial Day 2024?
InvestorPlace· 20 hours agoInvestors wondering if the stock market is open on Memorial Day in 2024 need look no further as we have the answer to that question! The stock market is...
12 Health Care Stocks Moving In Friday's Pre-Market Session - Akso Health Group (NASDAQ:AHG), Akari...
Benzinga· 24 hours agoJin Medical International ZJYL shares moved upwards by 14.92% to $3.23. The company's market cap stands at $505.5 million. Losers Verastem VSTM stock fell ...
Verastem (NASDAQ:VSTM) Stock Price Crosses Above 200-Day Moving Average of $10.14
ETF DAILY NEWS· 4 days agoVerastem, Inc. (NASDAQ:VSTM – Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average ...
NLST Stock Alert: Micron Faces $445 Million Verdict in Netlist Patent Trial
InvestorPlace· 21 hours agoNetlist (OTCMKTS:NLST) stock is in the news today as investors celebrate a court ruling concerning...
Verastem stock target cut on trial results, keeps Buy rating By Investing.com
Investing.com· 19 hours agoOn Friday, Verastem (NASDAQ:VSTM) shares plummeted approximately 63% following an update on clinical...